{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:07:32Z","timestamp":1787962052963,"version":"build-2784847793"},"reference-count":82,"publisher":"Walter de Gruyter GmbH","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Acute, life-threatening bleeding is a relatively common but critical presentation in the emergency department (ED), needing immediate assessment and intervention to reduce morbidity and mortality. Rapid identification of the bleeding source, evaluation of hemostatic function, and timely initiation of resuscitation are essential components of early management. Laboratory diagnostics plays a central role in this process, enabling clinicians to stratify the risk, guide therapeutic decisions, and predict outcomes. This opinion paper summarizes current evidence supporting the use of a core panel of laboratory tests in the initial evaluation of patients with emergency bleeding admitted to the ED. The leading characteristics of these initial tests encompass elevated diagnostic sensitivity, high precision and reproducibility, broad analytical measurement range, minimal turnaround time, low sample volume requirements, continuous availability, accessible measurement uncertainty, and proven clinical impact. The hypothetical core tests may include hemoglobin, blood lactate, prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, platelet count, viscoelastic assays, specific tests for measuring direct oral anticoagulants (DOACs), cardiac troponins and other organ-specific tests in patients with signs and symptoms of hypovolemic shock-induced organ failure. We believe that early implementation of a targeted, evidence-based initial laboratory diagnostic strategy in patients presenting to the ED with severely acute bleeding may support more effective resuscitation and transfusion protocols, reduce unnecessary interventions, and improve clinical outcomes.<\/jats:p>","DOI":"10.1515\/cclm-2025-0775","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T08:59:32Z","timestamp":1754989172000},"page":"2149-2162","source":"Crossref","is-referenced-by-count":5,"title":["Overview of laboratory diagnostics for immediate management of patients presenting to the emergency department with acute bleeding"],"prefix":"10.1515","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9523-9054","authenticated-orcid":false,"given":"Giuseppe","family":"Lippi","sequence":"first","affiliation":[{"name":"Section of Clinical Biochemistry , University of Verona , Verona , Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mullier","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Clinical Research (IREC) , UC Louvain , Ottignies-Louvain-la-Neuve , Belgium"},{"name":"Department of Laboratory Medicine , Hematology, CHU UCL Namur, UCLouvain , Ottignies-Louvain-la-Neuve , Belgium"},{"name":"Namur Thrombosis and Hemostasis Center (NTHC) , Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, UCLouvain , Ottignies-Louvain-la-Neuve , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Thonon","sequence":"additional","affiliation":[{"name":"Institute for Experimental and Clinical Research (IREC) , UC Louvain , Ottignies-Louvain-la-Neuve , Belgium"},{"name":"Namur Thrombosis and Hemostasis Center (NTHC) , Namur Research Institute for Life Sciences (NARILIS), CHU UCL Namur, UCLouvain , Ottignies-Louvain-la-Neuve , Belgium"},{"name":"Emergency Department , CHU UCL Namur, UCLouvain , Ottignies-Louvain-la-Neuve , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"additional","affiliation":[{"name":"Department of Haematology, Sydney Centres for Thrombosis and Haemostasis, Research and Education Network (REN) , Institute of Clinical Pathology and Medical Research (ICPMR), Hospital , Westmead , NSW , Australia"},{"name":"Faculty of Science and Health , Charles Sturt University , Wagga Wagga , NSW , Australia"},{"name":"School of Medical Sciences, Faculty of Medicine and Health , University of Sydney, Westmead Hospital , Westmead , NSW , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,8,13]]},"reference":[{"key":"2025103114402253766_j_cclm-2025-0775_ref_001","doi-asserted-by":"crossref","unstructured":"Lippi, G, Adcock, D, Favaloro, EJ. Understanding the \u201cphilosophy\u201d of laboratory hemostasis. Diagnosis (Berl). 2019;6:223\u20136. https:\/\/doi.org\/10.1515\/dx-2018-0099.","DOI":"10.1515\/dx-2018-0099"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_002","doi-asserted-by":"crossref","unstructured":"Lippi, G, Favaloro, EJ. Laboratory hemostasis: milestones in clinical chemistry and laboratory medicine. Clin Chem Lab Med 2013;51:91\u20137. https:\/\/doi.org\/10.1515\/cclm-2012-0387.","DOI":"10.1515\/cclm-2012-0387"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_003","doi-asserted-by":"crossref","unstructured":"Bezati, S, Ventoulis, I, Verras, C, Boultadakis, A, Bistola, V, Sbyrakis, N, et al.. Major bleeding in the emergency department: a practical guide for optimal management. J\u00a0Clin Med 2025;14:784. https:\/\/doi.org\/10.3390\/jcm14030784.","DOI":"10.3390\/jcm14030784"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_004","unstructured":"American College of Surgeons. ATLS\u00ae-advanced trauma life support student course manual, 10th ed.. Chicago, IL: American College of Surgeons; 2018:60611\u20133211 pp."},{"key":"2025103114402253766_j_cclm-2025-0775_ref_005","doi-asserted-by":"crossref","unstructured":"Magro, L, Stoppa, G, Venegoni, M, Pistorelli, C, Ricci, G, Moretti, U, et al.. Non-traumatic haemorrhagic adverse events: a cross-sectional study in emergency departments. J\u00a0Clin Toxicol 2018;8:2.","DOI":"10.4172\/2161-0495.1000377"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_006","doi-asserted-by":"crossref","unstructured":"Rossaint, R, Afshari, A, Bouillon, B, Cerny, V, Cimpoesu, D, Curry, N, et al.. The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition. Crit Care 2023;27:80. https:\/\/doi.org\/10.1186\/s13054-023-04327-7.","DOI":"10.1186\/s13054-023-04327-7"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_007","doi-asserted-by":"crossref","unstructured":"Mitra, B, Cameron, PA, Mori, A, Maini, A, Fitzgerald, M, Paul, E, et al.. Early prediction of acute traumatic coagulopathy. Resuscitation 2011;82:1208\u201313. https:\/\/doi.org\/10.1016\/j.resuscitation.2011.04.007.","DOI":"10.1016\/j.resuscitation.2011.04.007"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_008","doi-asserted-by":"crossref","unstructured":"Tonglet, ML, Minon, JM, Seidel, L, Poplavsky, JL, Vergnion, M. Prehospital identification of trauma patients with early acute coagulopathy and massive bleeding: results of a prospective non-interventional clinical trial evaluating the trauma induced coagulopathy clinical score (TICCS). Crit Care 2014;18:648. https:\/\/doi.org\/10.1186\/s13054-014-0648-0.","DOI":"10.1186\/s13054-014-0648-0"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_009","doi-asserted-by":"crossref","unstructured":"Peltan, ID, Rowhani-Rahbar, A, Vande Vusse, LK, Caldwell, E, Rea, TD, Maier, RV, et al.. Development and validation of a prehospital prediction model for acute traumatic coagulopathy. Crit Care 2016;20:371. https:\/\/doi.org\/10.1186\/s13054-016-1541-9.","DOI":"10.1186\/s13054-016-1541-9"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_010","doi-asserted-by":"crossref","unstructured":"Padoan, A, Sciacovelli, L, Aita, A, Antonelli, G, Plebani, M. Measurement uncertainty in laboratory reports: a tool for improving the interpretation of test results. Clin Biochem 2018;57:41\u20137. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.03.009.","DOI":"10.1016\/j.clinbiochem.2018.03.009"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_011","doi-asserted-by":"crossref","unstructured":"Plebani, M, Sciacovelli, L, Bernardi, D, Aita, A, Antonelli, G, Padoan, A. What information on measurement uncertainty should be communicated to clinicians, and how? Clin Biochem 2018;57:18\u201322. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.01.017.","DOI":"10.1016\/j.clinbiochem.2018.01.017"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_012","doi-asserted-by":"crossref","unstructured":"Devis, L, Arachchillage, DJ, Hardy, M, Mansour, A, Catry, E, Closset, M, et al.. Guidance-based appropriateness of hemostasis testing in the acute setting. Hamostaseologie 2025;45:24\u201348. https:\/\/doi.org\/10.1055\/a-2491-3631.","DOI":"10.1055\/a-2491-3631"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_013","doi-asserted-by":"crossref","unstructured":"Gell, DA. Structure and function of haemoglobins. Blood Cells Mol Dis 2018;70:13\u201342. https:\/\/doi.org\/10.1016\/j.bcmd.2017.10.006.","DOI":"10.1016\/j.bcmd.2017.10.006"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_014","unstructured":"Mondal, H, Zubair, M. Hematocrit. In: . StatPearls [Internet]. Treasure Island, FL. StatPearls Publishing; 2025."},{"key":"2025103114402253766_j_cclm-2025-0775_ref_015","doi-asserted-by":"crossref","unstructured":"Lee, G, Choi, S, Kim, K, Yun, JM, Son, JS, Jeong, SM, et al.. Association of hemoglobin concentration and its change with cardiovascular and all-cause mortality. J\u00a0Am Heart Assoc 2018;7:e007723. https:\/\/doi.org\/10.1161\/jaha.117.007723.","DOI":"10.1161\/JAHA.117.007723"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_016","doi-asserted-by":"crossref","unstructured":"Knottenbelt, JD. Low initial hemoglobin levels in trauma patients: an important indicator of ongoing hemorrhage. J\u00a0Trauma 1991;31:1396\u20139. https:\/\/doi.org\/10.1097\/00005373-199110000-00015.","DOI":"10.1097\/00005373-199110000-00015"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_017","doi-asserted-by":"crossref","unstructured":"Ryan, ML, Thorson, CM, Otero, CA, Vu, T, Schulman, CI, Livingstone, AS, et al.. Initial hematocrit in trauma: a paradigm shift? J\u00a0Trauma Acute Care Surg 2012;72:54\u20139. https:\/\/doi.org\/10.1097\/ta.0b013e31823d0f35.","DOI":"10.1097\/TA.0b013e31823d0f35"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_018","doi-asserted-by":"crossref","unstructured":"Thorson, CM, Van Haren, RM, Ryan, ML, Pereira, R, Olloqui, J, Guarch, GA, et al.. Admission hematocrit and transfusion requirements after trauma. J\u00a0Am Coll Surg 2013;216:65\u201373. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.09.011.","DOI":"10.1016\/j.jamcollsurg.2012.09.011"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_019","doi-asserted-by":"crossref","unstructured":"Thorson, CM, Ryan, ML, Van Haren, RM, Pereira, R, Olloqui, J, Otero, CA, et al.. Change in hematocrit during trauma assessment predicts bleeding even with ongoing fluid resuscitation. Am Surg 2013;79:398\u2013406. https:\/\/doi.org\/10.1177\/000313481307900430.","DOI":"10.1177\/000313481307900430"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_020","doi-asserted-by":"crossref","unstructured":"Kass, LE, Tien, IY, Ushkow, BS, Snyder, HS. Prospective crossover study of the effect of phlebotomy and intravenous crystalloid on hematocrit. Acad Emerg Med 1997;4:198\u2013201. https:\/\/doi.org\/10.1111\/j.1553-2712.1997.tb03740.x.","DOI":"10.1111\/j.1553-2712.1997.tb03740.x"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_021","doi-asserted-by":"crossref","unstructured":"Figueiredo, S, Taconet, C, Harrois, A, Hamada, S, Gauss, T, Raux, M, et al., Traumabase Group. How useful are hemoglobin concentration and its variations to predict significant hemorrhage in the early phase of trauma? A multicentric cohort study. Ann Intensive Care 2018;8:76. https:\/\/doi.org\/10.1186\/s13613-018-0420-8.","DOI":"10.1186\/s13613-018-0420-8"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_022","doi-asserted-by":"crossref","unstructured":"Carson, JL, Stanworth, SJ, Guyatt, G, Valentine, S, Dennis, J, Bakhtary, S, et al.. Red blood cell transfusion: 2023 AABB international guidelines. JAMA 2023;330:1892\u2013902. https:\/\/doi.org\/10.1001\/jama.2023.12914.","DOI":"10.1001\/jama.2023.12914"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_023","doi-asserted-by":"crossref","unstructured":"Van Gent, JM, Bavishi, D, Clements, TW, Dickey, JB, Hobbs, R, Bai, Y, et al.. Impact of massive transfusion activation on time to delivery of the first cooler and patient survival: a study of 4,313 consecutive activations. J\u00a0Am Coll Surg 2025;240:578\u201385. https:\/\/doi.org\/10.1097\/xcs.0000000000001282.","DOI":"10.1097\/XCS.0000000000001282"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_024","doi-asserted-by":"crossref","unstructured":"Ahn, HS, Lenet, T, Gilbert, RWD, Mallick, R, Shaw, JLV, Fergusson, DA, et al.. Accuracy of point-of-care testing devices for haemoglobin in the operating room: meta-analysis. BJS Open 2024;8:zrad148. https:\/\/doi.org\/10.1093\/bjsopen\/zrad148.","DOI":"10.1093\/bjsopen\/zrad148"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_025","doi-asserted-by":"crossref","unstructured":"Rabinowitz, JD, Enerb\u00e4ck, S. Lactate: the ugly duckling of energy metabolism. Nat Metab 2020;2:566\u201371. https:\/\/doi.org\/10.1038\/s42255-020-0243-4.","DOI":"10.1038\/s42255-020-0243-4"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_026","doi-asserted-by":"crossref","unstructured":"Baxter, J, Cranfield, KR, Clark, G, Harris, T, Bloom, B, Gray, AJ. Do lactate levels in the emergency department predict outcome in adult trauma patients? A systematic review. J\u00a0Trauma Acute Care Surg 2016;81:555\u201366. https:\/\/doi.org\/10.1097\/ta.0000000000001156.","DOI":"10.1097\/TA.0000000000001156"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_027","unstructured":"Sadrzadeh, SM, Talebzadeh, V, Mousavi, SM, Rezvani Kakhki, B, Vafadar Moradi, E, Feiz Disfani, H. Prognostic value of lactate levels in trauma patients\u2019 outcomes in emergency department. Bull Emerg Trauma 2025;13:32\u20136. https:\/\/doi.org\/10.30476\/beat.2025.103125.1519."},{"key":"2025103114402253766_j_cclm-2025-0775_ref_028","doi-asserted-by":"crossref","unstructured":"Zeng, F, Du, L, Ling, L. Lactate level as a predictor of outcomes in patients with acute upper gastrointestinal bleeding: a systematic review and meta-analysis. Exp Ther Med 2024;27:113. https:\/\/doi.org\/10.3892\/etm.2024.12401.","DOI":"10.3892\/etm.2024.12401"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_029","doi-asserted-by":"crossref","unstructured":"Jansen, TC, van Bommel, J, Mulder, PG, Rommes, JH, Schieveld, SJ, Bakker, J. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care 2008;12:R160. https:\/\/doi.org\/10.1186\/cc7159.","DOI":"10.1186\/cc7159"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_030","doi-asserted-by":"crossref","unstructured":"Attan\u00e0, P, Lazzeri, C, Picariello, C, Dini, CS, Gensini, GF, Valente, S. Lactate and lactate clearance in acute cardiac care patients. Eur Heart J Acute Cardiovasc Care 2012;1:115\u201321. https:\/\/doi.org\/10.1177\/2048872612451168.","DOI":"10.1177\/2048872612451168"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_031","doi-asserted-by":"crossref","unstructured":"Cannon, CM, Miller, RT, Grow, KL, Purcell, S, Nazir, N. Age-adjusted and expanded lactate thresholds as predictors of all-cause mortality in the emergency department. West J Emerg Med 2020;21:1249\u201357. https:\/\/doi.org\/10.5811\/westjem.2020.5.46811.","DOI":"10.5811\/westjem.2020.5.46811"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_032","doi-asserted-by":"crossref","unstructured":"Jyoti, D, Kumar, A, Halim, T, Hai, AA. The association between serum lactate concentration, base deficit, and mortality in polytrauma patients as a prognostic factor: an observational study. Cureus 2022;14:e28200. https:\/\/doi.org\/10.7759\/cureus.28200.","DOI":"10.7759\/cureus.28200"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_033","doi-asserted-by":"crossref","unstructured":"Ishii, K, Kinoshita, T, Kiridume, K, Watanabe, A, Yamakawa, K, Nakao, S, et al.. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study. Scand J Trauma Resusc Emerg Med 2019;27:25. https:\/\/doi.org\/10.1186\/s13049-019-0606-6.","DOI":"10.1186\/s13049-019-0606-6"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_034","doi-asserted-by":"crossref","unstructured":"Lamoine, S, Blanchet, JS, Lebreton, A, Boissier, E. Evaluation of a 4\u00a0min 4000g centrifugation protocol for routine coagulation assays. Blood Coagul Fibrinolysis 2025;36:191\u20138. https:\/\/doi.org\/10.1097\/MBC.0000000000001363.","DOI":"10.1097\/MBC.0000000000001363"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_035","doi-asserted-by":"crossref","unstructured":"Dincq, AS, Lessire, S, Pirard, G, Siriez, R, Guldenpfennig, M, Baudar, J, et al.. Reduction of the turn-around time for the measurement of rivaroxaban and apixaban: assessment of the performance of a rapid centrifugation method. Int J Lab Hematol 2018;40:e105\u20138. https:\/\/doi.org\/10.1111\/ijlh.12870.","DOI":"10.1111\/ijlh.12870"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_036","doi-asserted-by":"crossref","unstructured":"Frith, D, Goslings, JC, Gaarder, C, Maegele, M, Cohen, MJ, Allard, S, et al.. Definition and drivers of acute traumatic coagulopathy: clinical and experimental investigations. J\u00a0Thromb Haemost 2010;8:1919\u201325. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03945.x.","DOI":"10.1111\/j.1538-7836.2010.03945.x"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_037","doi-asserted-by":"crossref","unstructured":"Deras, P, Nouri, J, Martinez, O, Aubry, E, Capdevila, X, Charbit, J. Diagnostic performance of prothrombin time point-of-care to detect acute traumatic coagulopathy on admission: experience of 522 cases in trauma center. Transfusion 2018;58:1781\u201391. https:\/\/doi.org\/10.1111\/trf.14643.","DOI":"10.1111\/trf.14643"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_038","doi-asserted-by":"crossref","unstructured":"Favaloro, EJ, Pasalic, L, Curnow, J, Lippi, G. Laboratory monitoring or measurement of direct oral anticoagulants (DOACs): advantages, limitations and future challenges. Curr Drug Metab 2017;18:598\u2013608. https:\/\/doi.org\/10.2174\/1389200218666170417124035.","DOI":"10.2174\/1389200218666170417124035"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_039","doi-asserted-by":"crossref","unstructured":"Northup, PG, Garcia-Pagan, JC, Garcia-Tsao, G, Intagliata, NM, Superina, RA, Roberts, LN, et al.. Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American association for the study of liver diseases. Hepatology 2021;73:366\u2013413. https:\/\/doi.org\/10.1002\/hep.31646.","DOI":"10.1002\/hep.31646"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_040","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL clinical practice guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J\u00a0Hepatol 2022;76:1151\u201384. https:\/\/doi.org\/10.1016\/j.jhep.2021.09.003.","DOI":"10.1016\/j.jhep.2021.09.003"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_041","doi-asserted-by":"crossref","unstructured":"Thonon, H, Van Nieuwenhove, M, Thachil, J, Lippi, G, Hardy, M, Mullier, F. Hemostasis testing in the emergency department: a narrative review. Semin Thromb Hemost 2025;51:506\u201323. https:\/\/doi.org\/10.1055\/s-0044-1787661.","DOI":"10.1055\/s-0044-1787661"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_042","doi-asserted-by":"crossref","unstructured":"Tripodi, A, Lippi, G, Plebani, M. How to report results of prothrombin and activated partial thromboplastin times. Clin Chem Lab Med 2016;54:215\u201322. https:\/\/doi.org\/10.1515\/cclm-2015-0657.","DOI":"10.1515\/cclm-2015-0657"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_043","doi-asserted-by":"crossref","unstructured":"Bialkower, M, Garnier, G. Fibrinogen diagnostics in major hemorrhage. Crit Rev Anal Chem 2022;52:194\u2013209. https:\/\/doi.org\/10.1080\/10408347.2020.1793098.","DOI":"10.1080\/10408347.2020.1793098"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_044","doi-asserted-by":"crossref","unstructured":"McQuilten, ZK, Wood, EM, Bailey, M, Cameron, PA, Cooper, DJ. Fibrinogen is an independent predictor of mortality in major trauma patients: a five-year statewide cohort study. Injury 2017;48:1074\u201381. https:\/\/doi.org\/10.1016\/j.injury.2016.11.021.","DOI":"10.1016\/j.injury.2016.11.021"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_045","doi-asserted-by":"crossref","unstructured":"Ren, B, Zhang, Y, Chen, S, Dai, J, Chong, J, Chang, Z. Association between fibrinogen levels and prognosis in critically bleeding patients: exploration of the optimal therapeutic threshold. Eur J Trauma Emerg Surg 2025;51:219. https:\/\/doi.org\/10.1007\/s00068-025-02886-8.","DOI":"10.1007\/s00068-025-02886-8"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_046","unstructured":"Mu\u00f1oz, M, Stensballe, J, Ducloy-Bouthors, AS, Bonnet, MP, De Robertis, E, Fornet, I, et al.. Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus 2019;17:112\u201336. https:\/\/doi.org\/10.2450\/2019.0245-18."},{"key":"2025103114402253766_j_cclm-2025-0775_ref_047","doi-asserted-by":"crossref","unstructured":"Solomon, C, Baryshnikova, E, Tripodi, A, Schlimp, CJ, Sch\u00f6chl, H, Cadamuro, J, et al.. Fibrinogen measurement in cardiac surgery with cardiopulmonary bypass: analysis of repeatability and agreement of Clauss method within and between six different laboratories. Thromb Haemost 2014;112:109\u201317. https:\/\/doi.org\/10.1160\/th13-12-0997.","DOI":"10.1160\/TH13-12-0997"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_048","doi-asserted-by":"crossref","unstructured":"Stang, L, Nahirniak, S, Butcher, K, Szkotak, AJ. Dabigatran assessment in patients with acute complications using routine coagulation assays. Blood Coagul Fibrinolysis 2014;25:426\u201334. https:\/\/doi.org\/10.1097\/mbc.0000000000000056.","DOI":"10.1097\/MBC.0000000000000056"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_049","doi-asserted-by":"crossref","unstructured":"Favaloro, EJ, Pasalic, L, Lippi, G. Autoimmune diseases affecting hemostasis: a narrative review. Int J Mol Sci 2022;23:14715. https:\/\/doi.org\/10.3390\/ijms232314715.","DOI":"10.3390\/ijms232314715"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_050","doi-asserted-by":"crossref","unstructured":"Favaloro, EJ, Curnow, J, Pasalic, L. Laboratory assessment of factor VIII inhibitors: when is it required? A perspective informed by local practice. J\u00a0Clin Med 2024;14:13. https:\/\/doi.org\/10.3390\/jcm14010013.","DOI":"10.3390\/jcm14010013"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_051","doi-asserted-by":"crossref","unstructured":"Devreese, KMJ, Bertolaccini, ML, Branch, DW, de Laat, B, Erkan, D, Favaloro, EJ, et al.. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC subcommittee on lupus anticoagulant\/antiphospholipid antibodies. J\u00a0Thromb Haemost 2025;23:731\u201344. https:\/\/doi.org\/10.1016\/j.jtha.2024.10.022.","DOI":"10.1016\/j.jtha.2024.10.022"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_052","doi-asserted-by":"crossref","unstructured":"Favaloro, EJ, Pasalic, L, Lippi, G. Oral anticoagulation therapy: an update on usage and costs in the endemic COVID-19 era. J\u00a0Clin Med 2025;14:2591. https:\/\/doi.org\/10.3390\/jcm14082591.","DOI":"10.3390\/jcm14082591"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_053","doi-asserted-by":"crossref","unstructured":"Chen, J, Lv, M, Wu, S, Jiang, S, Xu, W, Qian, J, et al.. Editor\u2019s choice\u2013severe bleeding risks of direct oral anticoagulants in the prevention and treatment of venous thromboembolism: a network meta-analysis of randomised controlled trials. Eur J Vasc Endovasc Surg 2022;63:465\u201374. https:\/\/doi.org\/10.1016\/j.ejvs.2021.10.054.","DOI":"10.1016\/j.ejvs.2021.10.054"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_054","doi-asserted-by":"crossref","unstructured":"Geller, AI, Shehab, N, Lovegrove, MC, Weidle, NJ, Budnitz, DS. Bleeding related to oral anticoagulants: trends in US emergency department visits, 2016-2020. Thromb Res 2023;225:110\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2023.03.010.","DOI":"10.1016\/j.thromres.2023.03.010"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_055","doi-asserted-by":"crossref","unstructured":"Newgard, CD, Fischer, PE, Gestring, M, Michaels, HN, Jurkovich, GJ, Lerner, EB, Writing Group for the 2021 National Expert Panel on Field Triage, et al.. National guideline for the field triage of injured patients: recommendations of the national expert panel on field triage, 2021. J\u00a0Trauma Acute Care Surg 2022;93:e49\u201360. https:\/\/doi.org\/10.1097\/ta.0000000000003627.","DOI":"10.1097\/TA.0000000000003627"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_056","doi-asserted-by":"crossref","unstructured":"Lippi, G, Favaloro, EJ. Recent guidelines and recommendations for laboratory assessment of the direct oral anticoagulants (DOACs): is there consensus? Clin Chem Lab Med 2015;53:185\u201397. https:\/\/doi.org\/10.1515\/cclm-2014-0767.","DOI":"10.1515\/cclm-2014-0767"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_057","doi-asserted-by":"crossref","unstructured":"Douxfils, J, Ageno, W, Samama, CM, Lessire, S, Ten Cate, H, Verhamme, P, et al.. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J\u00a0Thromb Haemost 2018;16:209\u201319. https:\/\/doi.org\/10.1111\/jth.13912.","DOI":"10.1111\/jth.13912"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_058","doi-asserted-by":"crossref","unstructured":"Levy, JH, Shaw, JR, Castellucci, LA, Connors, JM, Douketis, J, Lindhoff-Last, E, et al.. Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH. J\u00a0Thromb Haemost 2024;22:2889\u201399. https:\/\/doi.org\/10.1016\/j.jtha.2024.07.009.","DOI":"10.1016\/j.jtha.2024.07.009"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_059","doi-asserted-by":"crossref","unstructured":"Sabor, L, Rapha\u00ebl, M, Dogn\u00e9, JM, Mullier, F, Douxfils, J. Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels. Thromb Res 2017;156:36\u20138. https:\/\/doi.org\/10.1016\/j.thromres.2017.05.024.","DOI":"10.1016\/j.thromres.2017.05.024"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_060","doi-asserted-by":"crossref","unstructured":"Lippi, G, Favaloro, EJ. Pearls and pitfalls in the measurement of direct oral anticoagulants. Semin Thromb Hemost 2024;50:1114\u201322. https:\/\/doi.org\/10.1055\/s-0044-1782196.","DOI":"10.1055\/s-0044-1782196"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_061","doi-asserted-by":"crossref","unstructured":"Jabet, A, Stepanian, A, Golmard, JL, Flaujac, C, Joly, BS, Gouin-Thibault, I, et al.. Are screening tests reliable to rule out direct oral anticoagulant plasma levels at various thresholds (30, 50, or 100\u00a0ng\/mL) in emergency situations? Chest 2018;153:288\u201390. https:\/\/doi.org\/10.1016\/j.chest.2017.09.047.","DOI":"10.1016\/j.chest.2017.09.047"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_062","doi-asserted-by":"crossref","unstructured":"Sakamoto, Y, Koami, H, Miike, T. Monitoring the coagulation status of trauma patients with viscoelastic devices. J\u00a0Intensive Care 2017;5:7. https:\/\/doi.org\/10.1186\/s40560-016-0198-4.","DOI":"10.1186\/s40560-016-0198-4"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_063","doi-asserted-by":"crossref","unstructured":"Reardon, B, Pasalic, L, Favaloro, EJ. The role of viscoelastic testing in assessing hemostasis: a challenge to standard laboratory assays? J\u00a0Clin Med 2024;13:3612. https:\/\/doi.org\/10.3390\/jcm13123612.","DOI":"10.3390\/jcm13123612"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_064","doi-asserted-by":"crossref","unstructured":"Bugaev, N, Como, JJ, Golani, G, Freeman, JJ, Sawhney, JS, Vatsaas, CJ, et al.. Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy: practice management guideline from the Eastern association for the surgery of trauma. J\u00a0Trauma Acute Care Surg 2020;89:999\u20131017. https:\/\/doi.org\/10.1097\/ta.0000000000002944.","DOI":"10.1097\/TA.0000000000002944"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_065","doi-asserted-by":"crossref","unstructured":"Fahrendorff, M, Oliveri, RS, Johansson, PI. The use of viscoelastic haemostatic assays in goal-directing treatment with allogeneic blood products-a systematic review and meta-analysis. Scand J Trauma Resusc Emerg Med 2017;25:39. https:\/\/doi.org\/10.1186\/s13049-017-0378-9.","DOI":"10.1186\/s13049-017-0378-9"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_066","doi-asserted-by":"crossref","unstructured":"Cochrane, C, Chinna, S, Um, JY, Dias, JD, Hartmann, J, Bradley, J, et al.. Site-of-care viscoelastic assay in major trauma improves outcomes and is cost neutral compared with standard coagulation tests. Diagnostics (Basel) 2020;10:486. https:\/\/doi.org\/10.3390\/diagnostics10070486.","DOI":"10.3390\/diagnostics10070486"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_067","doi-asserted-by":"crossref","unstructured":"Baksaas-Aasen, K, Gall, LS, Stensballe, J, Juffermans, NP, Curry, N, Maegele, M, et al.. Viscoelastic haemostatic assay augmented protocols for major trauma haemorrhage (ITACTIC): a randomized, controlled trial. Intensive Care Med 2021;47:49\u201359. https:\/\/doi.org\/10.1007\/s00134-020-06266-1.","DOI":"10.1007\/s00134-020-06266-1"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_068","doi-asserted-by":"crossref","unstructured":"Lippi, G, Favaloro, EJ, Buoro, S. Platelet transfusion thresholds: how low can we Go in respect to platelet counting? Semin Thromb Hemost 2020;46:238\u201344. https:\/\/doi.org\/10.1055\/s-0039-1696943.","DOI":"10.1055\/s-0039-1696943"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_069","doi-asserted-by":"crossref","unstructured":"Metcalf, RA, Nahirniak, S, Guyatt, G, Bathla, A, White, SK, Al-Riyami, AZ, et al.. Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines. JAMA 2025;29. https:\/\/doi.org\/10.1001\/jama.2025.7529.","DOI":"10.1001\/jama.2025.7529"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_070","doi-asserted-by":"crossref","unstructured":"Brown, LM, Call, MS, Margaret Knudson, M, Cohen, MJ, Trauma Outcomes Group. A normal platelet count may not be enough: the impact of admission platelet count on mortality and transfusion in severely injured trauma patients. J\u00a0Trauma 2011;71:S337\u201342. https:\/\/doi.org\/10.1097\/ta.0b013e318227f67c.","DOI":"10.1097\/TA.0b013e318227f67c"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_071","doi-asserted-by":"crossref","unstructured":"Hamada, SR, Garrigue, D, Nougue, H, Meyer, A, Boutonnet, M, Meaudre, E, TraumaBase Group, et al.. Impact of platelet transfusion on outcomes in trauma patients. Crit Care 2022;26:49. https:\/\/doi.org\/10.1186\/s13054-022-03928-y.","DOI":"10.1186\/s13054-022-03928-y"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_072","doi-asserted-by":"crossref","unstructured":"Kleinveld, DJB, van Amstel, RBE, Wirtz, MR, Geeraedts, LMG, Goslings, JC, Hollmann, MW, et al.. Platelet-to-red blood cell ratio and mortality in bleeding trauma patients: a systematic review and meta-analysis. Transfusion 2021;61:S243\u201351. https:\/\/doi.org\/10.1111\/trf.16455.","DOI":"10.1111\/trf.16455"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_073","doi-asserted-by":"crossref","unstructured":"Thygesen, K, Alpert, JS, Jaffe, AS, Chaitman, BR, Bax, JJ, Morrow, DA, Executive Group on behalf of the Joint European Society, of Cardiology (ESC)\/American College of Cardiology (ACC)\/American Heart Association (AHA)\/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction, et al.. Fourth universal definition of myocardial infarction (2018). Circulation 2018;138:e618\u201351. https:\/\/doi.org\/10.1161\/cir.0000000000000617.","DOI":"10.1161\/CIR.0000000000000617"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_074","doi-asserted-by":"crossref","unstructured":"Iqbal, U, Siddique, O, Jameel, A, Anwar, H, Chaudhary, A. Prognostic significance of elevated cardiac troponin in acute gastrointestinal bleeding. Gastroenterol Res 2017;10:238\u201343. https:\/\/doi.org\/10.14740\/gr893w.","DOI":"10.14740\/gr893w"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_075","doi-asserted-by":"crossref","unstructured":"Kousa, O, Addasi, Y, Machanahalli Balakrishna, A, Pajjuru, VSK, Bardwell, JK, Walters, RW, et al.. Elevated troponin in patients with acute gastrointestinal bleeding: prevalence, predictors and outcomes. Future Cardiol 2022;18:709\u201317. https:\/\/doi.org\/10.2217\/fca-2021-0143.","DOI":"10.2217\/fca-2021-0143"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_076","doi-asserted-by":"crossref","unstructured":"Iser, DM, Thompson, AJ, Sia, KK, Yeomans, ND, Chen, RY. Prospective study of cardiac troponin I release in patients with upper gastrointestinal bleeding. J\u00a0Gastroenterol Hepatol 2008;23:938\u201342. https:\/\/doi.org\/10.1111\/j.1440-1746.2007.04940.x.","DOI":"10.1111\/j.1440-1746.2007.04940.x"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_077","doi-asserted-by":"crossref","unstructured":"Galli, M, Laborante, R, Ortega-Paz, L, Franchi, F, Rollini, F, D\u2019Amario, D, et al.. Factor XI inhibitors in early clinical trials: a meta-analysis. Thromb Haemost 2023;123:576\u201384. https:\/\/doi.org\/10.1055\/a-2043-0346.","DOI":"10.1055\/a-2043-0346"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_078","doi-asserted-by":"crossref","unstructured":"Harrington, J, Piccini, JP, Alexander, JH, Granger, CB, Patel, MR. Clinical evaluation of factor XIa inhibitor drugs: JACC review topic of the week. J\u00a0Am Coll Cardiol 2023;81:771\u20139. https:\/\/doi.org\/10.1016\/j.jacc.2022.11.057.","DOI":"10.1016\/j.jacc.2022.11.057"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_079","doi-asserted-by":"crossref","unstructured":"Godier, A, Lasne, D, Martin, AC, Pernod, G, Albaladejo, P, De Maistre, E, et al.. French working group on perioperative haemostasis (Groupe d\u2019Int\u00e9r\u00eat en H\u00e9mostase P\u00e9riop\u00e9ratoire). Management of bleeding and invasive procedures in patients treated with anti-factor XI(a) anticoagulants: proposals from the French working group on perioperative haemostasis and French society of thrombosis and haemostasis. Res Pract Thromb Haemost 2025;9:102860. https:\/\/doi.org\/10.1016\/j.rpth.2025.102860.","DOI":"10.1016\/j.rpth.2025.102860"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_080","doi-asserted-by":"crossref","unstructured":"Gouin-Thibault, I, Lecompte, T, Lasne, D. Anticoagulant drugs targeting factor XI\/XIa and coagulation tests: we urgently need reliable pharmacodynamic data. J\u00a0Thromb Haemost 2025;23:1464\u20138. https:\/\/doi.org\/10.1016\/j.jtha.2025.02.025.","DOI":"10.1016\/j.jtha.2025.02.025"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_081","doi-asserted-by":"crossref","unstructured":"Tomizawa, M, Shinozaki, F, Hasegawa, R, Shirai, Y, Motoyoshi, Y, Sugiyama, T, et al.. Patient characteristics with high or low blood urea nitrogen in upper gastrointestinal bleeding. World J Gastroenterol 2015;21:7500\u20135. https:\/\/doi.org\/10.3748\/wjg.v21.i24.7500.","DOI":"10.3748\/wjg.v21.i24.7500"},{"key":"2025103114402253766_j_cclm-2025-0775_ref_082","doi-asserted-by":"crossref","unstructured":"Helsloot, D, Fitzgerald, M, Lefering, R, Verelst, S, Missant, C, TraumaRegister, DGU. Trauma-induced disturbances in ionized calcium levels correlate parabolically with coagulopathy, transfusion, and mortality: a multicentre cohort analysis from the TraumaRegister DGU\u00ae. Crit Care 2023;27:267. https:\/\/doi.org\/10.1186\/s13054-023-04541-3.","DOI":"10.1186\/s13054-023-04541-3"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0775\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0775\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:42:48Z","timestamp":1761921768000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/cclm-2025-0775\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,13]]},"references-count":82,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,6,26]]},"published-print":{"date-parts":[[2025,10,27]]}},"alternative-id":["10.1515\/cclm-2025-0775"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2025-0775","relation":{},"ISSN":["1434-6621","1437-4331"],"issn-type":[{"value":"1434-6621","type":"print"},{"value":"1437-4331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,13]]}}}